Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARCH: Epoetin beta for anemia in cervical cancer under radiochemotherapy
NCT00046969Phase 4Completed
- Sponsor
- AGO Study Group
- Start
- Jul 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin beta in anemia (2 arms), sponsored by AGO Study Group. Primary endpoints: Number of treatment failures within 6 months after beginning radiochemotherapy and Overall survival after RCT. Started Jul 2002; status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00046969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046969.